Efficacy and safety of radiotherapy combined with chemoimmunotherapy versus chemoimmunotherapy alone as first-line treatment for metachronous oligorecurrent esophageal squamous cell carcinoma

PurposeMetachronous oligorecurrence is usually defined as oligometastatic disease diagnosed more than 6 months after primary tumor diagnosis in the absence of active systemic therapy. This study aimed to assess the safety and efficacy of radiotherapy combined with chemoimmunotherapy (RCIT) versus ch...

Descripció completa

Dades bibliogràfiques

Autors principals:	Xiaoyan Lv, Yuan Wang, Jingyi Ai, Siyu Chen, Yi Tan, Xinbing Li, Xintong Yan, Jun Wang
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-06-01
Col·lecció:	Frontiers in Oncology
Matèries:	chemoimmunotherapy esophageal squamous cell carcinoma metachronous oligorecurrence oligometastatic disease radiotherapy
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1803137/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!